Roche donates 5.65 mn flu antivirals to WHO
May 12th, 2009 - 2:34 pm ICT by IANSGeneva, May 12 (DPA) Swiss Pharmaceutical giant Roche announced Tuesday it was donating 5.65 million doses of its anti-viral drug to the World Health Organisation (WHO) to help replenish stocks depleted by the response to the influenza A (H1N1) outbreak.
The WHO had distributed nearly over 2.4 million doses of anti-viral drugs to some 72 countries in the last week. These doses came from a previous Roche donation in 2006, which has now been given out.
Roche also announced that its production of the anti-viral could reach up to 110 million courses of treatment over the next five months.
“Roche has been rapidly increasing production of Tamiflu at multiple points in the supply chain,” David Reddy, the head of the drugmaker’s task force for pandemics, said in a statement, using the brand name of the anti-viral.
“Actual production output is dependent upon continued demand from governments for pandemic stockpiles of Tamiflu.”
The countries who received the drugs are mostly the least-developed nations as well as Mexico, which has been one of the areas hardest hit by the outbreak of the new virus, also known as swine flu.
While the WHO has not provided a breakdown of how much each country received, Mexican envoys to the United Nations in Geneva said they received one million doses.
The WHO has said in the last two weeks that it was in contact with private sector companies about supplies of anti-virals and had called on them to prepare to ramp up production.
The latest donation from Roche, based in Basel, Switzerland, would see regional stockpile managed by WHO pumped up with two million treatment courses of the anti-viral Tamiflu.
Another three million doses will go to replenish the rapid response stockpiles held by the pharmaceutical to be deployed when needed by the WHO.
A new stockpile would be established with 650,000 treatment courses of a new paediatric version of the anti-viral, known generically as oseltamivir, which has been deemed to be effective against the new virus.
The latest figures from the UN’s health agency showed 30 countries have officially reported 4,694 cases of the infection. Mexico had 1,626 laboratory confirmed human cases, including 48 deaths and the US reported 2,532 infections, including three deaths.
Canada had one death from 284 instances of the disease and Costa Rica reported eight cases, including one death.
No other countries with infections reported fatalities. The WHO also said North America was the only region showing signs of sustained human-to-human transmission.
The virus is being considered mostly mild at this point and the health agency has not recommended travel restrictions or prohibitions on eating pork products.
- Does India have enough drugs to beat swine flu? - Apr 28, 2009
- Swiss flu medicine producer Roche ups its preparedness - Apr 29, 2009
- Hyderabad firm claims boost up of anti-swine flu drug - May 01, 2009
- Swiss flu medicine firm sees stock rise on back of outbreak - Apr 27, 2009
- Flu virus was not lab creation, WHO says - May 15, 2009
- No swine flu case in India, flu medicine stocks being beefed (Second Lead) - Apr 30, 2009
- Swine flu epidemic spreads; Mexico death toll 152 (Roundup) - Apr 28, 2009
- H1N1 drug Tamiflu effectiveness questioned - Dec 12, 2009
- Landmark agreement improves global preparedness for influenza pandemics - Apr 18, 2011
- Anti-virals may not work for elderly swine flu victims - Jul 28, 2009
- WHO rejects criticism it acted slowly on swine flu - May 01, 2009
- First case of Tamiflu resistance in pandemic swine flu emerges in Denmark - Jul 01, 2009
- WHO: 700 deaths from swine flu recorded - Jul 22, 2009
- Obama wants $1.5 bn to fight swine flu - Apr 29, 2009
- Anti-tumor drug that also fights flu virus - Mar 01, 2011
Tags: anti viral drugs, anti virals, antivirals, basel switzerland, developed nations, five months, influenza, new virus, oseltamivir, outbreak, pandemic, pharmaceutical giant, private sector companies, rapid response, roche, stockpile, stockpiles, swine flu, tamiflu, world health organisation